ATNM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Actinium Pharmaceuticals Inc (ATNM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators are bearish, the financial performance shows significant losses, and there are no positive catalysts or strong trading signals to support a buy decision at this time.
The MACD histogram is negative and expanding (-0.00557), indicating bearish momentum. The RSI is neutral at 32.147, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 1.045), with no clear upward momentum.
NULL identified. No recent news or significant trading trends from hedge funds, insiders, or Congress. No AI Stock Picker or SwingMax signals.
The stock's financial performance is weak, with a significant YoY drop in net income (-55.64%) and EPS (-56.76%). The market sentiment is bearish, and the stock is underperforming compared to its pivot levels.
In Q3 2025, revenue remained flat at $90,000 (0.00% YoY), while net income dropped significantly to -$5,131,000 (-55.64% YoY). EPS also declined to -0.16 (-56.76% YoY). Gross margin remained stable at 100%.
No recent analyst ratings or price target changes available for evaluation.
